Using machine learning algorithms to develop a clinical decision-making tool for COVID-19 inpatients

Loading...
Thumbnail Image

Date published

Free to read from

Authors

Vepa, Abhinav
Saleem, Amer
Rakhshan, Kambiz
Daneshkhah, Alireza
Sedighi, Tabassom
Shohaimi, Shamarina
Omar, Amr
Salari, Nader
Chatrabgoun, Omid
Dharmaraj, Diana

Supervisor/s

Journal Title

Journal ISSN

Volume Title

Publisher

Department

Course name

ISSN

1661-7827

Format

Citation

Vepa A, Saleem A, Rakhshan K, et al., (2021) Using machine learning algorithms to develop a clinical decision-making tool for COVID-19 inpatients. International Journal of Environmental Research and Public Health, Volume 18, Issue 12, June 2021, Article number 6228

Abstract

Background: Within the UK, COVID-19 has contributed towards over 103,000 deaths. Although multiple risk factors for COVID-19 have been identified, using this data to improve clinical care has proven challenging. The main aim of this study is to develop a reliable, multivariable predictive model for COVID-19 in-patient outcomes, thus enabling risk-stratification and earlier clinical decision-making. Methods: Anonymised data consisting of 44 independent predictor variables from 355 adults diagnosed with COVID-19, at a UK hospital, was manually extracted from electronic patient records for retrospective, case–control analysis. Primary outcomes included inpatient mortality, required ventilatory support, and duration of inpatient treatment. Pulmonary embolism sequala was the only secondary outcome. After balancing data, key variables were feature selected for each outcome using random forests. Predictive models were then learned and constructed using Bayesian networks. Results: The proposed probabilistic models were able to predict, using feature selected risk factors, the probability of the mentioned outcomes. Overall, our findings demonstrate reliable, multivariable, quantitative predictive models for four outcomes, which utilise readily available clinical information for COVID-19 adult inpatients. Further research is required to externally validate our models and demonstrate their utility as risk stratification and clinical decision-making tools.

Description

Software Description

Software Language

Github

Keywords

Bayesian network, COVID-19, SARS CoV, random forest, risk stratification, synthetic minority oversampling technique (SMOTE)

DOI

Rights

Attribution 4.0 International

Funder/s

Relationships

Relationships

Resources